DB
Danielle Brill Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
33
Avg Return
Past Year
Past Year
15%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Credit Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $110 |
33%
upside
| 3 | +34% |
0
%
| 9 Mar ‘26 3 months ago |
|
|
|
Buy
Maintained
| $83 |
18%
upside
| 3 | +5.3% |
0
%
| 27 Feb ‘26 3 months ago |
|
|
|
Buy
Maintained
| $95 |
40%
upside
| 4 | +13% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
Buy
Maintained
| $140 |
12%
downside
| 4 | +0.01% |
0
%
| 17 Feb ‘26 3 months ago |
|
|
|
Buy
Maintained
| $38 |
4%
downside
| 3 | +22% |
0
%
| 29 Jan ‘26 4 months ago |
|
|
|
Buy
Maintained
| $60 |
104%
upside
| 2 | +25% |
0
%
| 8 Jan ‘26 5 months ago |
|
|
|
Hold
Maintained
| $22 |
34%
downside
| 2 | -42% |
–
| 8 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $45 |
32%
upside
| 2 | -9.3% |
0
%
| 8 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $530 |
84%
upside
| 3 | +4.3% |
0
%
| 8 Jan ‘26 5 months ago |
|
|
|
Buy
Maintained
| $190 |
63%
upside
| 4 | +49% |
0
%
| 16 Dec ‘25 6 months ago |
|
|
|
Buy
Initiated
| $47 |
670%
upside
| 1 | -52% |
0
%
| 14 Oct ‘25 8 months ago |
|
|
|
Market Perform
Initiated
| – | – | 1 | – |
–
| 3 Sep ‘25 9 months ago |
|
|
|
Buy
Initiated
| $24 |
47%
upside
| 1 | +20% |
0
%
| 21 Jul ‘25 11 months ago |
|